These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 7076570)
1. Isolation and characterization of two 16-membered lactones: 20-deoxorosaramicin and 20-deoxo-12,13-desepoxy-12,13-dehydrorosaramicin aglycones, from a mutant strain of Micromonospora rosaria. Vaughan RW; Lotvin J; Puar MS; Patel M; Kershner A; Kalyanpur MG; Marquez J; Waitz JA J Antibiot (Tokyo); 1982 Feb; 35(2):251-3. PubMed ID: 7076570 [No Abstract] [Full Text] [Related]
2. Isolation and characterization of 23-O-mycinosyl-20-dihydro-rosamicin: a new rosamicin analogue derived from engineered Micromonospora rosaria. Anzai Y; Sakai A; Li W; Iizaka Y; Koike K; Kinoshita K; Kato F J Antibiot (Tokyo); 2010 Jun; 63(6):325-8. PubMed ID: 20414322 [No Abstract] [Full Text] [Related]
3. Function of cytochrome P450 enzymes RosC and RosD in the biosynthesis of rosamicin macrolide antibiotic produced by Micromonospora rosaria. Iizaka Y; Higashi N; Ishida M; Oiwa R; Ichikawa Y; Takeda M; Anzai Y; Kato F Antimicrob Agents Chemother; 2013 Mar; 57(3):1529-31. PubMed ID: 23274670 [TBL] [Abstract][Full Text] [Related]
4. A new mycinosyl rosamicin derivative produced by an engineered Micromonospora rosaria mutant with a cytochrome P450 gene disruption introducing the D-mycinose biosynthetic gene. Iizaka Y; Higashi N; Li W; Fukumoto A; Anzai Y; Kato F J Ind Microbiol Biotechnol; 2014 Sep; 41(9):1451-6. PubMed ID: 25047182 [TBL] [Abstract][Full Text] [Related]
5. Multistep bioconversion of 20-deoxo-20-dihydro-12,13-deepoxy-12,13-dehydrorosaranolide to 22-hydroxy-23-O-mycinosyl-20-deoxo-20-dihydro-12,13-deepoxy-rosaramicin. Lee BK; Puar MS; Patel M; Bartner P; Lotvin J; Munayyer H; Waitz JA J Antibiot (Tokyo); 1983 Jun; 36(6):742-4. PubMed ID: 6874596 [No Abstract] [Full Text] [Related]
6. Effect of intercalating dyes on the production of antibiotics by Micromonospora rosaria and Micromonospora purpurea. Kim KS; Pai HS; Lee SY; Ryu DD Enzyme Microb Technol; 1990 Aug; 12(8):564-70. PubMed ID: 1366780 [TBL] [Abstract][Full Text] [Related]
7. New analogs of rosaramicin isolated from a Micromonospora strain. II. Structure determination. Nakajima S; Kojiri K; Morishima H; Okanishi M J Antibiot (Tokyo); 1990 Aug; 43(8):1006-9. PubMed ID: 2211347 [No Abstract] [Full Text] [Related]
8. Genetic recombination in Micromonospora rosaria by protoplast fusion. Ryu DD; Kim KS; Cho NY; Pai HS Appl Environ Microbiol; 1983 Jun; 45(6):1854-8. PubMed ID: 6881962 [TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of plasmids from Micromonospora zionensis and Micromonospora rosaria. Oshida T; Takeda K; Yamaguchi T; Ohshima S; Ito Y Plasmid; 1986 Jul; 16(1):74-6. PubMed ID: 3016783 [TBL] [Abstract][Full Text] [Related]
10. Chimeramycins: new macrolide antibiotics produced by hybrid biosynthesis. Omura S; Sadakane N; Tanaka Y; Matsubara H J Antibiot (Tokyo); 1983 Jul; 36(7):927-30. PubMed ID: 6860432 [No Abstract] [Full Text] [Related]
11. Biosynthesis of tylosin: oxidations of 5-O-mycaminosylprotylonolide at C-20 and C-23 with a cell-free extract from Streptomyces fradiae. Omura S; Tanaka H; Tsukui M Biochem Biophys Res Commun; 1982 Jul; 107(2):554-60. PubMed ID: 7126228 [No Abstract] [Full Text] [Related]
12. Production of rosamicin derivatives in Micromonospora rosaria by introduction of D-mycinose biosynthetic gene with PhiC31-derived integration vector pSET152. Anzai Y; Iizaka Y; Li W; Idemoto N; Tsukada S; Koike K; Kinoshita K; Kato F J Ind Microbiol Biotechnol; 2009 Aug; 36(8):1013-21. PubMed ID: 19408026 [TBL] [Abstract][Full Text] [Related]
13. Production of a hybrid 16-membered macrolide antibiotic by genetic engineering of Micromonospora sp. TPMA0041. Sakai A; Mitsumori A; Furukawa M; Kinoshita K; Anzai Y; Kato F J Ind Microbiol Biotechnol; 2012 Nov; 39(11):1693-701. PubMed ID: 22842988 [TBL] [Abstract][Full Text] [Related]
14. Hybrid biosynthesis of a new macrolide antibiotic by a daunomycin-producing microorganism. Sadakane N; Tanaka Y; Omura S J Antibiot (Tokyo); 1983 Jul; 36(7):921-2. PubMed ID: 6885644 [No Abstract] [Full Text] [Related]
15. New analogues of rosaramicin isolated from a Micromonospora strain. I. Taxonomy, fermentation, isolation and physico-chemical and biological properties. Funaishi K; Kawamura K; Satoh F; Hiramatsu M; Hagiwara M; Okanish M J Antibiot (Tokyo); 1990 Aug; 43(8):938-47. PubMed ID: 2088343 [TBL] [Abstract][Full Text] [Related]
16. New tylosin analogs produced by mutants of Streptomyces fradiae. Kiyoshima K; Takada K; Yamamoto M; Kubo K; Okamoto R; Fukagawa Y; Ishikura T; Naganawa H; Sawa T; Takeuchi T J Antibiot (Tokyo); 1987 Aug; 40(8):1123-30. PubMed ID: 3680024 [TBL] [Abstract][Full Text] [Related]
17. X-ray crystallography of protylonolide and absolute configuration of tylosin. Omura S; Matsubara H; Nakagawa A; Furusaki A; Matsumoto T J Antibiot (Tokyo); 1980 Aug; 33(8):915-7. PubMed ID: 7429997 [No Abstract] [Full Text] [Related]
18. Ammonium ion suppresses the biosynthesis of tylosin aglycone by interference with valine catabolism in Streptomyces fradiae. Omura S; Tanaka Y; Mamada H; Masuma R J Antibiot (Tokyo); 1983 Dec; 36(12):1792-4. PubMed ID: 6662823 [No Abstract] [Full Text] [Related]
19. New cirramycin-family antibiotics F-1 and F-2. Selection of producer mutants, fermentation, isolation, structural elucidation and antibacterial activity. Sawada Y; Tsuno T; Miyaki T; Naito T; Oki T J Antibiot (Tokyo); 1989 Feb; 42(2):242-53. PubMed ID: 2925516 [TBL] [Abstract][Full Text] [Related]
20. Deepoxidation of 16-membered epoxyenone macrolide antibiotics. II. Chemical deepoxidation by dissolving metal reduction. Mutoh Y; Shimauchi Y; Fukagawa Y; Ishikura T; Lein J J Antibiot (Tokyo); 1984 Feb; 37(2):127-9. PubMed ID: 6706848 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]